zolmitriptan has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dixon, R; Warrander, A | 1 |
| Delvaux, M; Dixon, R; French, S; Kemp, J; Leclerc, V; Rautureau, J; Sellers, M | 1 |
1 trial(s) available for zolmitriptan and Liver Dysfunction
| Article | Year |
|---|---|
Effect of hepatic impairment on the pharmacokinetics of zolmitriptan.
Topics: Adult; Aged; Area Under Curve; Biotransformation; Blood Pressure; Female; Half-Life; Humans; Liver Diseases; Male; Middle Aged; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines | 1998 |
1 other study(ies) available for zolmitriptan and Liver Dysfunction
| Article | Year |
|---|---|
The clinical pharmacokinetics of zolmitriptan.
Topics: Absorption; Adult; Case-Control Studies; Female; Humans; Liver Diseases; Male; Migraine Disorders; Oxazoles; Oxazolidinones; Serotonin Receptor Agonists; Tissue Distribution; Tryptamines | 1997 |